Filters
Intestinal toxicity of chemotherapy in patients with ovarian carcinoma and follow neopterin level in urine as the marker of immune system activation in patients with ovarian carcinoma (NR8156)
chemotherapy in patients with ovarian carcinoma as the marker of immune system activationmonitoring of intestinal toxicity during chemotherapy in patients with ovarian carcinoma by help of LAMA test and by help of...
FD - Onkologie a hematologie
- 2004 - 2006 •
- 1 081 tis. Kč •
- 1 075 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2004 - 1. 1. 2006
Uznané náklady
Podpora ze státního rozpočtu (99%)
Poskytovatel: Ministerstvo zdravotnictví
DNA ploidy and selected biological markers value for treatment selection and its impact on clinical outcome in endometrial or ovarian carcinoma - prospective study. (NS9975)
Cytometric DNA analysis of endometrial and ovarian carcinoma will be performed using fresh/frozen tissue and standard technique. We will choose more radical therapy in DNA aneuploid tumors. We will perform data analysis in relation ...
FK - Gynekologie a porodnictví
- 2008 - 2011 •
- 4 509 tis. Kč •
- 4 315 tis. Kč •
- MZ
Řešení projektu: 1. 7. 2008 - 31. 12. 2011
Uznané náklady
Podpora ze státního rozpočtu (96%)
Poskytovatel: Ministerstvo zdravotnictví
Immunohistochemical quantification of prognostic factors in ovarian cancer and correlation with clinical history of the disease (NR8363)
The subject of the project is to demonstrate significant prognostic and predictive determinants for invasive ovarian carcinoma by immunohistochemical examination kinetics, angiogenic potential, and presence of tumour-infiltrating T ...
FK - Gynekologie a porodnictví
- 2005 - 2007 •
- 731 tis. Kč •
- 675 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2005 - 31. 12. 2007
Uznané náklady
Podpora ze státního rozpočtu (92%)
Poskytovatel: Ministerstvo zdravotnictví
Complex morphological, immunohistochemical, molecular genetic and clinico-pathological analysis of rare types of ovarian carcinomas (NV19-03-00007)
Most (about 70%) malignant epithelial ovarian tumors are high grade serous carcinomas. The second most frequent are endometrioid and clear cell carcinomas (approximately 10% each), followed by low grade serous (<5%) and muc...
Pathology
- 2019 - 2022 •
- 19 091 tis. Kč •
- 19 091 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2019 - 31. 12. 2022
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
The ralationship of cytokines to the invasivity of the ovarian carcinoma cells and origine of metastases. (IZ4126)
FK - Gynekologie a porodnictví
- 1997 - 1999 •
- 1 957 tis. Kč •
- 1 957 tis. Kč •
- MZ
Řešení projektu: 1. 1. 1997 - 1. 1. 1999
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Role of tumor specific immune response and circulating tumour cells in the peripheral blood for the clinical course of ovarian cancer. (NT14533)
Ovarian carcinoma is a disease with frequent relapses and high mortality. Bearing this in mind, it is important to search for new therapeutical strategies aimed for eradication of minimal residual disease. It is likely that new know...
FK - Gynekologie a porodnictví
- 2013 - 2015 •
- 4 370 tis. Kč •
- 4 370 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2013 - 31. 12. 2015
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Importance of ovarian carcinoma genetic profile in prevention of development, progression and suboptimal treatment response (NU20-09-00174)
Ovarian carcinoma (OC) is a leading cause of death among gynecological cancers. In order to improve prevention, screening and reduction of high mortality, it is necessary to reveal genetic variability of OC and its association with ...
Human genetics
- 2020 - 2024 •
- 15 028 tis. Kč •
- 12 521 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2020 - 31. 12. 2024
Uznané náklady
Podpora ze státního rozpočtu (83%)
Poskytovatel: Ministerstvo zdravotnictví
Changes in Chemoresistance/Chemosensitivity of Ovarian Cancer Cells (NS9737)
of ovarian carcinoma cells and the length of disease free interval, overall survival1)The changes in chemoresistance/chemosensitivity of ovarian cancer cells by means of MTT -WST-1 test and assessment of resistance protein...
FK - Gynekologie a porodnictví
- 2008 - 2010 •
- 2 537 tis. Kč •
- 2 537 tis. Kč •
- MZ
Řešení projektu: 1. 7. 2008 - 31. 12. 2010
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Ovarian cancer and therapy of infertility using in vitro fertilization - the risk factors analysis by system for data minig SHLUK and artefitial neural network NEUL3. (NO7696)
Retrospective exploratory computer analysis of the data about assisted reproduction IVF cycles on I.department of gynecology and obstetrics in Brno. Analysis of the potential relation between the occurence of ovarian carcinoma and i...
FK - Gynekologie a porodnictví
- 2003 - 2005 •
- 1 096 tis. Kč •
- 1 089 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2003 - 1. 1. 2005
Uznané náklady
Podpora ze státního rozpočtu (99%)
Poskytovatel: Ministerstvo zdravotnictví
Complex Care of Ovarian Carcinoma Patients (NS10258)
The project fulfils two main aims of departmental program R&D for years 2008-2011 - the individualization and control of ovarian cancer treatment using tumor for the diagnostics, control and optimization of ovarian cancer treatment....
FD - Onkologie a hematologie
- 2009 - 2011 •
- 4 668 tis. Kč •
- 4 668 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2009 - 31. 12. 2011
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
- 1 - 10 out of 433